Dosage form development, manufacture, and stability studies of mitragynine
Ended Awarded Last action
- Contract number
- 75N95020F00001
- Awardee
-
Purdue University UEI YRXVL4JYCEF5
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $704,709
Award facts
- Opportunity
-
- CRO Support for NCATS Drug Product Development, Manufacture, and Stability Studies Pre-Solicitation · 75N95020R00046 · Posted Jul 21, 2016
- CRO Support for NCATS Drug Product Development, Manufacture, and Stability Studies Award Notice · Posted Aug 1, 2017
- Contract value 100% obligated
- $704,709.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- West Lafayette, IN 47907, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Original award | $704,709 |
About this award
This federal contract award to Purdue University is for the development, manufacture, and stability studies of mitragynine, a naturally occurring compound, under the National Center for Advancing Translational Sciences (NCATS) Drug Product Development Studies 2017-2022 indefinite delivery vehicle. The $704,709 cost-reimbursement contract has a period of performance through June 30, 2025. Purdue University, a non-profit institution of higher education and research, will provide the requested services as the prime contractor. The National Institutes of Health's NCATS, which focuses on translating scientific discoveries into new medical treatments, is the funding agency for this award. Purdue University, as a long-standing federal contractor and grantee, has extensive experience supporting various government missions through research, technology development, and subject matter expertise across domains like defense, space, agriculture, health, and the environment.
Quick answers
Who was awarded contract 75N95020F00001?
75N95020F00001 was awarded to Purdue University by National Institute on Drug Abuse (National Institutes of Health) on September 18, 2020.
How much is contract 75N95020F00001 worth?
The government has obligated $704,709 on 75N95020F00001.
Which agency awarded contract 75N95020F00001?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95020F00001, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Is contract 75N95020F00001 an order under another contract?
Yes. 75N95020F00001 is a delivery order under HHSN271201700022I, an indefinite delivery contract, on NCATS Drug Product Development Studies 2017-2022.
Was contract 75N95020F00001 competed?
The extent of competition for 75N95020F00001 was full and open competition. The government received 4 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award